Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure

Antiplatelet agents, sarpogrelate (SAR), a 5-HT(2A) receptor antagonist, and cilostazol (CIL), a phosphodiesterase III (PDE-III) inhibitor, are used for the treatment of peripheral vascular disease. We tested whether these agents affect cardiac function and subcellular remodelling in congestive hear...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanganalmath, Santosh K, Babick, Andrea P, Barta, Judit, Kumamoto, Hideo, Takeda, Nobuakiya, Dhalla, Naranjan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918089/
https://www.ncbi.nlm.nih.gov/pubmed/18088389
http://dx.doi.org/10.1111/j.1582-4934.2007.00197.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918089/
https://www.ncbi.nlm.nih.gov/pubmed/18088389
http://dx.doi.org/10.1111/j.1582-4934.2007.00197.x

Ejemplares similares